Da: Chiron Media, Wallingford, Regno Unito
EUR 82,77
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Da: Majestic Books, Hounslow, Regno Unito
EUR 97,44
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Elsevier Science Health Science, 2016
ISBN 10: 0323416969 ISBN 13: 9780323416962
Da: Revaluation Books, Exeter, Regno Unito
EUR 95,93
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 9.06x6.14x0.71 inches. In Stock.
Condizione: New.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 109,60
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Elsevier - Health Sciences Division, 2016
ISBN 10: 0323416969 ISBN 13: 9780323416962
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 105,52
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 92,11
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Elsevier Health Sciences Apr 2016, 2016
ISBN 10: 0323416969 ISBN 13: 9780323416962
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 91,99
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can progress to end stage liver disease with resultant cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, several extrahepatic conditions may be linked to NAFLD including cardiovascular disease, insulin requiring and type 2 diabetes mellitus, obstructive sleep apnea, colonic adenomas, hyperuricemia, vitamin D deficiency, hyperferritinemia, pancreatic steatosis, hypothyroidism, and polycystic ovarian syndrome. Therapies for NAFLD are evolving rapidly. This issue will analyze patient demographics, risk factors, pathophysiology, patient presentation, and treatments for NAFLD. Englisch.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 103,96
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can progress to end stage liver disease with resultant cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, several extrahepatic conditions may be linked to NAFLD including cardiovascular disease, insulin requiring and type 2 diabetes mellitus, obstructive sleep apnea, colonic adenomas, hyperuricemia, vitamin D deficiency, hyperferritinemia, pancreatic steatosis, hypothyroidism, and polycystic ovarian syndrome. Therapies for NAFLD are evolving rapidly. This issue will analyze patient demographics, risk factors, pathophysiology, patient presentation, and treatments for NAFLD.